Skip NavigationSkip to Content
Return Return to Search Results

Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay

  1. Author:
    Wheat, L. J.
    Hackett, E.
    Durkin, M.
    Connolly, P.
    Petraitiene, R.
    Walsh, T. J.
    Knox, K.
    Hage, C.

  2. Author Address

    MiraVista Diagnost, Indianapolis, IN 46241 USA. NCI, CRC, Pediat Oncol Branch, Immunocompromised Host Sect, Bethesda, MD 20892 USA. SAIC Frederick Inc, Lab Anim Sci Program, Frederick, MD 21702 USA. Indiana Univ, Sch Med, Dept Pulm Med, Roudebush Vet Adm Hosp, Indianapolis, IN 46202 USA.;Wheat, LJ, MiraVista Diagnost, 4444 Decatur Blvd,Suite 300, Indianapolis, IN 46241 USA.;jwheat@miravistalabs.com
    1. Year: 2007
    2. Date: May
  2. Journal: Clinical and Vaccine Immunology
    1. 14
    2. 5
    3. Pages: 638-640
  4. Type of Article: Article
  5. ISSN: 1556-6811
  1. Abstract:

    We observed false-positive results in the Platelia Aspergillus enzyme-linked immunoassay (EIA) for specimens from patients with histoplasmosis and mice with experimental infection. Platelia Aspergillus EIA-positive specimens were negative in the second-generation Histoplasma antigen EIA. Care must be taken to exclude histoplasmosis for patients with positive Platelia Aspergillus EIA results.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1128/cvi.00479-06
  3. View record in Web of Science®
  4. WOS: 000246681800022

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel